SCHEMBL967576

SCHEMBL967576

Cc1ccc2c3c(oc2n1)CN(CC(=O)N1CCN(C2CCC2)CC1)CC3

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.42
HRH3 Q9Y5N1 4/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HPGD P15428 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
RAB9A P51151 1/20 0.34
MAPK1 P28482 1/20 0.34
USP28 Q96RU2 1/20 0.34
USP25 Q9UHP3 1/20 0.34
G6PD P11413 1/20 0.34
CACNA1B Q00975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL969868 0.88 PARP1 (0.42) PARP1HRH3NPSR1ALDH1A1KDM4E
SCHEMBL969376 0.86 PARP1 (0.40) PARP1HRH3HTTNPSR1ALDH1A1
SCHEMBL967379 0.84 HRH3 (0.39) PARP1HRH3HTTNPSR1ALDH1A1
SCHEMBL967205 0.83 PARP1 (0.39) PARP1HRH3HTTNPSR1ALDH1A1
SCHEMBL971322 0.82 PARP1 (0.39) PARP1HRH3HTTNPSR1ALDH1A1
SCHEMBL12920066 0.82 PARP1 (0.40) PARP1HRH3NPSR1ALDH1A1KDM4E
SCHEMBL967866 0.82 PARP1 (0.40) PARP1HRH3NPSR1ALDH1A1KDM4E
SCHEMBL969526 0.81 HRH3 (0.39) PARP1HRH3NPSR1ALDH1A1KDM4E
SCHEMBL967329 0.80 PARP1 (0.39) PARP1HRH3NPSR1ALDH1A1KDM4E
SCHEMBL967373 0.80 PARP1 (0.52) PARP1HRH3HTTNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 PARP1 2898/4885HRH3 1/4885HTT 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.